Levodopa effect on spontaneous speech in Parkinson's disease

被引:1
作者
Bayram, Ece [1 ]
Aslanbaba, Eda [2 ]
Akbostanci, Muhittin Cenk [1 ,2 ]
机构
[1] Ankara Univ, Dept Interdisciplinary Neurosci, Ibni Sina Hastanesi, Talatpasa Bulv 82, TR-06230 Ankara, Turkey
[2] Ankara Univ, Dept Neurol, Ibni Sina Hastanesi, Talatpasa Bulv 82, TR-06230 Ankara, Turkey
关键词
Levodopa; Word production; Verb; Noun; Parkinson's disease; MONTREAL COGNITIVE ASSESSMENT; NONDEMENTED PATIENTS; DIAGNOSTIC-CRITERIA; VERB GENERATION; TASK; STIMULATION; FLUENCY; MOTOR; MOCA;
D O I
10.1016/j.jneuroling.2019.03.001
中图分类号
H0 [语言学];
学科分类号
030303 ; 0501 ; 050102 ;
摘要
Parkinson's disease (PD) is associated with verb deficits detected with tasks including picture naming and verbal fluency. However, these deficits are not frequently reported by the patients themselves. Levodopa, the gold standard for motor symptoms in PD, has been previously implicated to improve these verb deficits. We evaluated the effect of levodopa by using a spontaneous speech task which is more naturalistic than the previously used tasks to detect verb deficits. Thirty PD patients, and 30 age-, gender-, years of education-matched healthy controls were included. Patients were tested while motor 'on' and 'off. Levodopa did not affect spontaneous speech, although it improved the motor symptoms. Compared to controls, PD patients produced shorter and a lower number of sentences. The verb deficit was independent of cognitive or motor performance. The pathophysiology of motor symptoms and verb deficits most likely differ, and levodopa does not improve verb deficits during spontaneous speech.
引用
收藏
页码:194 / 198
页数:5
相关论文
共 50 条
  • [21] Levodopa Effect and Motor Function in Late Stage Parkinson's Disease
    Rosqvist, Kristina
    Horne, Malcolm
    Hagell, Peter
    Iwarsson, Susanne
    Nilsson, Maria H.
    Odin, Per
    JOURNAL OF PARKINSONS DISEASE, 2018, 8 (01) : 59 - 70
  • [22] Normalization effect of levodopa on hierarchical brain function in Parkinson's disease
    Guo, Tao
    Xuan, Min
    Zhou, Cheng
    Wu, Jingjing
    Gao, Ting
    Bai, Xueqin
    Liu, Xiaocao
    Gu, Luyan
    Liu, Ruiqi
    Song, Zhe
    Gu, Quanquan
    Huang, Peiyu
    Pu, Jiali
    Zhang, Baorong
    Xu, Xiaojun
    Guan, Xiaojun
    Zhang, Minming
    NETWORK NEUROSCIENCE, 2022, 6 (02) : 552 - 569
  • [23] Levodopa: Effect on Cell Death and the Natural History of Parkinson's Disease
    Olanow, C. Warren
    MOVEMENT DISORDERS, 2015, 30 (01) : 37 - 44
  • [24] Levodopa effect upon functional balance of Parkinson's disease patients
    Nova, IC
    Perracini, MR
    Ferraz, HB
    PARKINSONISM & RELATED DISORDERS, 2004, 10 (07) : 411 - 415
  • [25] Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naive Patients With Parkinson's Disease
    Conti, Valeria
    Izzo, Viviana
    Russillo, Maria Claudia
    Picillo, Marina
    Amboni, Marianna
    Scaglione, Cesa L. M.
    Nicoletti, Alessandra
    Cani, Ilaria
    Cicero, Calogero E.
    De Bellis, Emanuela
    Charlier, Bruno
    Giudice, Valentina
    Somma, Gerardina
    Corbi, Graziamaria
    Barone, Paolo
    Filippelli, Amelia
    Pellecchia, Maria Teresa
    FRONTIERS IN MEDICINE, 2022, 9
  • [26] Levodopa Effect on Basal Ganglia Motor Circuit in Parkinson's Disease
    Gao, Lin-Lin
    Zhang, Jia-Rong
    Chan, Piu
    Wu, Tao
    CNS NEUROSCIENCE & THERAPEUTICS, 2017, 23 (01) : 76 - 86
  • [27] Effect of Levodopa on Reward and Impulsivity in a Rat Model of Parkinson's Disease
    Carvalho, Miguel M.
    Campos, Filipa L.
    Marques, Mariana
    Soares-Cunha, Carina
    Kokras, Nikolaos
    Dalla, Christina
    Leite-Almeida, Hugo
    Sousa, Nuno
    Salgado, Antonio J.
    FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2017, 11
  • [28] The effect of levodopa benserazide hydrochloride on homocysteinemia levels in patients with Parkinson's disease and treatment of hyperhomocysteinemia
    Guo, G.
    Xu, S.
    Cao, L. -D.
    Wu, Q. -Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (11) : 2409 - 2412
  • [29] Complications of levodopa therapy in Parkinson's disease
    Dubow, Jordan
    Olanow, C. Warren
    EXPERT OPINION ON ORPHAN DRUGS, 2019, 7 (09): : 391 - 397
  • [30] Unmasking levodopa resistance in Parkinson's disease
    Nonnekes, Jorik
    Timmer, Monique H. M.
    de Vries, Nienke M.
    Rascol, Olivier
    Helmich, Rick C.
    Bloem, Bastiaan R.
    MOVEMENT DISORDERS, 2016, 31 (11) : 1602 - 1609